Annarita DiLorenzo

Title: Annarita DiLorenzo: Innovator in Vascular and Non-Vascular Disease Treatment

Introduction

Annarita DiLorenzo is a prominent inventor based in Ithaca, NY (US). She has made significant contributions to the field of medical science, particularly in the development of innovative treatments for vascular and non-vascular diseases. Her work focuses on engineered proteins that enhance therapeutic delivery.

Latest Patents

Annarita holds a patent for "ApoM-Fc fusion proteins, complexes thereof with sphingosine 1-phosphate (S1P), and methods for treating vascular and non-vascular diseases." This patent describes an engineered phospholipid or lysophospholipid chaperone derived from an Apolipoprotein M (ApoM)-Fc fusion protein. The innovation provides a safe, efficient, and effective means of delivering S1P to endothelial cells and various tissues throughout the body. She has 1 patent to her name.

Career Highlights

Annarita is affiliated with the Children's Medical Center Corporation, where she continues to advance her research and development efforts. Her work has the potential to significantly impact the treatment of various diseases, showcasing her dedication to improving patient outcomes.

Collaborations

Throughout her career, Annarita has collaborated with notable professionals in her field, including Timothy T Hla and Steven L Swendeman. These partnerships have further enriched her research and contributed to the advancement of medical science.

Conclusion

Annarita DiLorenzo is a trailblazer in the field of medical innovation, with her patented work paving the way for new treatment methodologies. Her contributions are vital in the ongoing quest to enhance healthcare solutions for vascular and non-vascular diseases.